Research Analysts’ Recent Ratings Changes for Tenet Healthcare (THC)

A number of research firms have changed their ratings and price targets for Tenet Healthcare (NYSE: THC):

• 6/9/2025 – Tenet Healthcare had its price target raised by analysts at Morgan Stanley from $175.00 to $210.00. They now have an “overweight” rating on the stock.
• 6/7/2025 – Tenet Healthcare was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 6/2/2025 – Tenet Healthcare was upgraded by analysts at Stephens to a “strong-buy” rating.
• 6/2/2025 – Tenet Healthcare had its price target raised by analysts at Barclays PLC from $171.00 to $215.00. They now have an “overweight” rating on the stock.
• 5/30/2025 – Tenet Healthcare was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 5/29/2025 – Tenet Healthcare was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating. They now have a $195.00 price target on the stock, up previously from $150.00.
• 5/22/2025 – Tenet Healthcare was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 5/14/2025 – Tenet Healthcare had its price target raised by analysts at Bank of America Co. from $165.00 to $180.00. They now have a “buy” rating on the stock.
• 5/12/2025 – Tenet Healthcare had its price target raised by analysts at Truist Financial Co. from $175.00 to $190.00. They now have a “buy” rating on the stock.
• 5/5/2025 – Tenet Healthcare had its price target raised by analysts at Morgan Stanley from $165.00 to $175.00. They now have an “overweight” rating on the stock.
• 5/5/2025 – Tenet Healthcare had its price target raised by analysts at The Goldman Sachs Group, Inc. from $134.00 to $154.00. They now have a “neutral” rating on the stock.
• 5/1/2025 – Tenet Healthcare was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 4/30/2025 – Tenet Healthcare had its price target raised by analysts at Barclays PLC from $161.00 to $171.00. They now have an “overweight” rating on the stock.
• 4/30/2025 – Tenet Healthcare had its price target raised by analysts at Royal Bank of Canada from $183.00 to $189.00. They now have an “outperform” rating on the stock.
• 4/30/2025 – Tenet Healthcare had its price target raised by analysts at UBS Group AG from $217.00 to $230.00. They now have a “buy” rating on the stock.
• 4/15/2025 – Tenet Healthcare had its “neutral” rating reaffirmed by analysts at Robert W. Baird. They now have a $137.00 price target on the stock, down previously from $153.00.
• 4/15/2025 – Tenet Healthcare was downgraded by analysts at Baird R W from a “strong-buy” rating to a “hold” rating.

Tenet Healthcare Stock Performance

THC traded down $8.25 during midday trading on Tuesday, hitting $157.94. 1,083,161 shares of the company were exchanged, compared to its average volume of 1,520,767. The company’s 50 day simple moving average is $145.01 and its 200 day simple moving average is $137.07. The firm has a market capitalization of $14.67 billion, a price-to-earnings ratio of 4.90, a price-to-earnings-growth ratio of 1.02 and a beta of 1.65. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25. Tenet Healthcare Co. has a 1-year low of $109.82 and a 1-year high of $174.14.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $4.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $1.25. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. The company had revenue of $5.22 billion for the quarter, compared to the consensus estimate of $5.15 billion. During the same period last year, the firm earned $3.22 EPS. The firm’s revenue for the quarter was down 2.5% compared to the same quarter last year. As a group, sell-side analysts predict that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.

Insider Activity

In other news, EVP Paola M. Arbour sold 7,738 shares of the firm’s stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $173.00, for a total transaction of $1,338,674.00. Following the sale, the executive vice president now directly owns 20,110 shares in the company, valued at $3,479,030. This trade represents a 27.79% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard W. Fisher sold 836 shares of Tenet Healthcare stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $173.16, for a total value of $144,761.76. Following the completion of the sale, the director now owns 11,292 shares in the company, valued at approximately $1,955,322.72. The trade was a 6.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 54,121 shares of company stock worth $8,846,305 in the last ninety days. Company insiders own 0.81% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Institutional investors have recently bought and sold shares of the company. US Bancorp DE lifted its stake in Tenet Healthcare by 0.8% in the 1st quarter. US Bancorp DE now owns 8,620 shares of the company’s stock worth $1,159,000 after purchasing an additional 68 shares in the last quarter. Lindbrook Capital LLC lifted its stake in Tenet Healthcare by 5.3% in the 1st quarter. Lindbrook Capital LLC now owns 1,427 shares of the company’s stock worth $192,000 after purchasing an additional 72 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Tenet Healthcare by 9.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 940 shares of the company’s stock worth $119,000 after purchasing an additional 80 shares in the last quarter. Covestor Ltd lifted its stake in Tenet Healthcare by 10.4% in the 1st quarter. Covestor Ltd now owns 873 shares of the company’s stock worth $117,000 after purchasing an additional 82 shares in the last quarter. Finally, GeoWealth Management LLC lifted its stake in Tenet Healthcare by 39.8% in the 4th quarter. GeoWealth Management LLC now owns 295 shares of the company’s stock worth $37,000 after purchasing an additional 84 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.